Clinical trial of mirazid in treatment of human fascioliasis in Ezbet El - Bakly [Tamyia Center] Al - Fayoum Governorate

ABSTRACT

A field survey was done in Ezbet EI-Bakly, El-Fayoum Governorate, Egypt to assess the efficacy and safety of mirazid in the treatment of human fascioliasis. Among 1019 individuals examined for parasitosis, the prevalence of fascioliasis was 1.7% and the geometric mean egg count [GMEC] was 33.2 eggs/g stools. About 23.5% of the fascioliasis patients were asymptomatic. It was concluded that mirazid [or myrrh extract of Commiphora molmol] is safe and effective in the treatment of human fascioliasis under the field conditions